附录二Pubmed检索的结膜松弛症论文目录
1. Chhadva P, Alexander A, McClellan AL, et al. The impact of conjunctivochalasis on dry eye symptoms and signs［J］. Invest Ophthalmol Vis Sci, 2015, 56（5）: 2867-2871.
2. Pult H, Riede-Pult BH. Impact of conjunctival folds on central tear meniscus height［J］. Invest Ophthalmol Vis Sci, 2015, 56（3）: 1459-1466.
3. Wang X, Chen F, Tang X. The clinical comparison of conjunctival resection with conjunctival resection and sclera fixation in the treatment of conjunctivochalasis［J］. Zhonghua Yan Ke Za Zhi, 2014, 50（9）: 687-90.
4. Le Q, Cui X, Xiang J, et al. Impact of conjunctivochalasis on visual quality of life: a community population survey［J］. PLoS One, 2014, 9（10）: e110821.
5. Tahiri Joutei Hassani R, Liang H, El Sanharawi M, et al. En-face optical coherence tomography as a novel tool for exploring the ocular surface: a pilot comparative study to conventional B-scans and in vivo confocal microscopy［J］. Ocul Surf, 2014, 12（4）: 285-306.
6. Tse DT, Erickson BP, Tse BC. The BLICK mnemonic for clinical-anatomical assessment of patients with epiphora［J］. Ophthal Plast Reconstr Surg, 2014, 30（6）: 450-458.
7. Balci O. Clinical characteristics of patients with conjunctivochalasis［J］. Clin Ophthalmol, 2014, 8: 1655-1660.
8. Petris CK, Holds JB. Medial conjunctival resection for tearing associated with conjunctivochalasis［J］. Ophthal Plast Reconstr Surg, 2014, 30（4）: 355.
9. Mocan MC, Irkec M. Medial conjunctival resection for tearing associated with conjunctivochalasis［J］. Ophthal Plast Reconstr Surg, 2014, 30（4）: 354.
10. Kantaputra PN, Kaewgahya M, Wiwatwongwana A, et al. Cutis laxa with pulmonary emphysema, conjunctivochalasis, nasolacrimal duct obstruction, abnormal hair, and a novel FBLN5 mutation［J］. Am J Med Genet A, 2014, 164A（9）: 2370-2377.
11. Yamada K, Ueta M, Sotozono C, et al. Upregulation of Toll-like receptor 5 expression in the conjunctival epithelium of various human ocular surface diseases［J］. Br J Ophthalmol, 2014, 98（8）: 1116-1119.
12. Kocabeyoglu S, Mocan MC, Irkec M. The influence of glaucoma medications on ocular surface disease in primary open-angle glaucoma patients with and without conjunctivochalasis［J］. Acta Ophthalmol, 2014, 92（7）: e592-593.
13. Nakasato H, Uemoto R, Meguro A, et al. Treatment of symptomatic inferior conjunctivochalasis by ligation［J］. Acta Ophthalmol, 2014, 92（5）: e411-412.
14. Moon H, Yoon JH, Hyun SH, et al. Short-term influence of aspirating speculum use on dry eye after cataract surgery: a prospective study［J］. Cornea, 2014, 33（4）: 373-375.
15. Ahn JM, Choi CY, Seo KY. Surgical approach with high-frequency radiowave electrosurgery for superior limbic keratoconjunctivitis［J］. Cornea, 2014, 33（2）: 210-214.
16. Acera A, Vecino E, Duran JA. Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis［J］. Invest Ophthalmol Vis Sci, 2013, 54（13）: 8285-8291.
17. Zhang XR, Liu YX, Sheng X, et al. Clinical observation of lymphangiectasis in conjunctivochalasis cases［J］. Zhonghua Yan Ke Za Zhi, 2013, 49（6）: 547-550.
18. Tong L, Lan W, Sim HS, et al. Conjunctivochalasis is the precursor to pterygium［J］. Med Hypotheses, 2013, 81（5）: 927-930.
19. Zheng X, Kamao T, Yamaguchi M, et al. New method for evaluation of early phase tear clearance by anterior segment optical coherence tomography［J］. Acta Ophthalmol, 2014, 92（2）: e105-111.
20. Zhang XR, Zou HD, Li QS, et al. Comparison study of two diagnostic and grading systems for conjunctivochalasis［J］. Chin Med J （Engl）, 2013, 126（16）: 3118-3123.
21. Kim KH, Ko AY, Ryu JS, et al. Effect of electrocauterization on the inflammation of the conjunctiva in experimental animal model［J］. Korean J Ophthalmol, 2013, 27（4）: 282-287.
22. Petris CK, Holds JB. Medial conjunctival resection for tearing associated with conjunctivochalasis［J］. Ophthal Plast Reconstr Surg, 2013, 29（4）: 304-307.
23. Mimura T, Yamagami S, Kamei Y, et al. Influence of axial length on conjunctivochalasis［J］. Cornea, 2013, 32（8）: 1126-1130.
24. Huang Y, Sheha H, Tseng SC. Conjunctivochalasis interferes with tear flow from fornix to tear meniscus［J］. Ophthalmology, 2013, 120（8）: 1681-1687.
25. Suzuki H, Shiwa T, Oharazawa H, et al. Simultaneous treatment of pterygium and temporal conjunctivochalasis［J］. J Nippon Med Sch, 2013, 80（1）: 74-77.
26. Yamamoto Y, Yokoi N, Higashihara H, et al. Clinical characteristics of short tear film breakup time （BUT） -type dry eye［J］. Nihon Ganka Gakkai Zasshi, 2012, 116（12）: 1137-1143.
27. Kocabeyoglu S, Mocan MC, Irkec M, et al. Conjunctivochalasis as a contributing factor for the development of ocular surface disease in medically treated glaucoma patients［J］. J Glaucoma, 2014, 23（5）: 333-336.
28. Zhang XR, Zhang ZY, Hoffman MR, et al. The effect of age and conjunctivochalasis on conjunctival thickness［J］. Curr Eye Res, 2013, 38（3）: 331-334.
29. Zhang XR, Zhang ZY, Hoffman MR. Electrocoagulative surgical procedure for treatment of conjunctivochalasis［J］. Int Surg, 2012, 97（1）: 90-93.
30. Ueta M, Sotozono C, Yamada K, et al. Expression of prostaglandin E receptor subtype EP4 in conjunctival epithelium of patients with ocular surface disorders: case-control study［J］. BMJ Open, 2012, 2（5）: pii: e001330.
31. Gumus K, Pflugfelder SC. Increasing prevalence and severity of conjunctivochalasis with aging detected by anterior segment optical coherence tomography［J］. Am J Ophthalmol, 2013, 155（2）: 238-242.
32. Wang S, Ke M, Cai X, et al. An improved surgical method to correct conjunctivochalasis: conjunctival semiperitomy based on corneal limbus with subconjunctival cauterization［J］. Can J Ophthalmol, 2012, 47（5）: 418-422.
33. Whitaker JK, Alexander P, Chau DY, et al. Severe conjunctivochalasis in association with classic type Ehlers-Danlos syndrome［J］. BMC Ophthalmol, 2012, 12: 47.
34. Jiang LH, Zhang XR, Zhang JH, et al. The clinical observation of conjunctivochalasis crescent conjunctival resection with bipolar coagulation［J］. Zhonghua Yan Ke Za Zhi, 2012, 48（5）: 409-412.
35. Yang HS, Choi S. New approach for conjunctivochalasis using an argon green laser［J］. Cornea, 2013, 32（5）: 574-578.
36. Shin KH, Hwang JH, Kwon JW. New approach for conjunctivochalasis with argon laser photocoagulation［J］. Can J Ophthalmol, 2012, 47（4）: 380-382.
37. Santos-Bueso E, Vico-Ruiz E, García-Sánchez J. Eye pathology in the paintings by Anton van Dyck: Cornelius van der Geest’conjunctivochalasis［J］. Arch Soc Esp Oftalmol, 2012, 87（7）: 228-229.
38. Guo P, Zhang SZ, He H, et al. PTX3 controls activation of matrix metalloproteinase 1 and apoptosis inconjunctivochalasis fibroblasts［J］. Invest Ophthalmol Vis Sci, 2012, 53（7）: 3414-3423.
39. Doss LR, Doss EL, Doss RP. Paste-pinch-cut conjunctivoplasty: subconjunctival fibrin sealant injection in the repair ofconjunctivochalasis［J］. Cornea, 2012, 31（8）: 959-962.
40. Guo P, Zhang SZ, He H, et al. TSG-6 controls transcription and activation of matrix metalloproteinase 1 inconjunctivochalasis［J］. Invest Ophthalmol Vis Sci, 2012, 53（3）: 1372-1380.
41. Nakasato S, Uemoto R, Mizuki N. Thermocautery for inferior conjunctivochalasis［J］. Cornea, 2012, 31（5）: 514-519.
42. Li QS, Zhang XR, Xiang MH, et al. Clinical evaluation of the quantitative locator for conjunctiva resection used as an instrument for the treatment of conjunctivochalasis［J］. Chin Med J （Engl）, 2011, 124（13）: 1983-1987.
43. Fodor E, Kosina-Hagyó K, Bausz M, et al. Increased tear osmolarity in patients with severe cases of conjunctivochalasis［J］. Curr Eye Res, 2012, 37（1）: 80-84.
44. Kashima T, Akiyama H, Miura F, et al. Improved subjective symptoms of conjunctivochalasis using bipolar diathermy method for conjunctival shrinkage［J］. Clin Ophthalmol, 2011, 5: 1391-1396.
45. Ueta M, Sotozono C, Yokoi N, et al. Prostaglandin E receptor subtype EP3 expression in human conjunctival epithelium and its changes in various ocular surface disorders［J］. PLoS One, 2011, 6（9）: e25209.
46. Liang L, Sheha H, Fu Y, et al. Ocular surface morbidity in eyes with senile sunken upper eyelids［J］. Ophthalmology, 2011, 118（12）: 2487-2492.
47. Hara S, Kojima T, Ishida R, et al. Evaluation of tear stability after surgery for conjunctivochalasis［J］. Optom Vis Sci, 2011, 88（9）: 1112-1118.
48. Mimura T, Mori M, Obata H, et al. Conjunctivochalasis: associations with pinguecula in a hospital-based study［J］. Acta Ophthalmol, 2012, 90（8）: 773-782.
49. Haefliger IO, Keskinaslan I, Piffaretti JM, et al. Improvement of chronic epiphora symptoms after surgery in patients with different preoperative schirmer-test values［J］. Klin Monbl Augenheilkd, 2011, 228（4）: 318-321.
50. Zhang X, Li Q, Zou H, et al. Assessing the severity of conjunctivochalasis in a senile population: a community-based epidemiology study in Shanghai, China［J］. BMC Public Health, 2011, 11: 198.
51. Mimura T, Usui T, Yamagami S, et al. Relationship between conjunctivochalasis and refractive error［J］. Eye Contact Lens, 2011, 37（2）: 71-78.
52. Schmitz J. Conjunctivochalasis and subconjunctival hemorrhage［J］. Ophthalmology, 2010, 117（12）: 2444. 53. Ueta M. Regulation of ocular surface inflammation by prostaglandin E receptor subtype EP3［J］. Cornea, 2010, 29 Suppl 1: S57-61.
54. Gumus K, Crockett CH, Pflugfelder SC. Anterior segment optical coherence tomography: a diagnostic instrument for conjunctivochalasis［J］. Am J Ophthalmol, 2010, 150（6）: 798-806.
55. Acera A, Suárez T, Rodríguez-Agirretxe I, et al. Changes in tear protein profile in patients with conjunctivochalasis［J］. Cornea, 2011, 30（1）: 42-49.
56. Mimura T, Yamagami S, Mori M, et al. Contact lens-induced subconjunctival hemorrhage［J］. Am J Ophthalmol, 2010, 150（5）: 656-665.
57. Fodor E, Barabino S, Montaldo E, et al. Quantitative evaluation of ocular surface inflammation in patients with different grade of conjunctivochalasis［J］. Curr Eye Res, 2010, 35（8）: 665-669.
58. Sun Q, Wang Y, Zhou YL, et al. A comparative study of efficacy for treating conjunctivochalasis with positioning and quantified patch［J］. Zhonghua Yan Ke Za Zhi, 2010, 46（5）: 405-409.
59. Youm DJ, Kim JM, Choi CY. Simple surgical approach with high-frequency radio-wave electrosurgery forconjunctivochalasis［J］. Ophthalmology, 2010, 117（11）: 2129-2133.
60. Nicholas S, Wells A. Subconjunctival hemorrhage and conjunctivochalasis［J］. Ophthalmology, 2010, 117（6）: 1276-1277.
61. Li QS, Zhang XR, Zou HD, et al. Epidemiologic study of conjunctivochalasis in populations equal or over 60 years old in Caoyangxincun community of Shanghai, China［J］. Zhonghua Yan Ke Za Zhi, 2009, 45（9）: 793-798.
62. Ward SK, Wakamatsu TH, Dogru M, et al. The role of oxidative stress and inflammation in conjunctivochalasis［J］. Invest Ophthalmol Vis Sci, 2010, 51（4）: 1994-2002.
63. Dal Pizzol MM, Roggia MF, Kwitko S, et al. Use of fibrin glue in ocular surgery［J］. Arq Bras Oftalmol, 2009, 72（3）: 308-312.
64. Mimura T, Usui T, Yamagami S, et al. Subconjunctival hemorrhage and conjunctivochalasis［J］. Ophthalmology, 2009, 116（10）: 1880-1886.
65. Chun YS, Kim JC. Treatment of superior limbic keratoconjunctivitis with a large-diameter contact lens and Botulium Toxin A［J］. Cornea, 2009, 28（7）: 752-758.
66. Zhang XR, Xiang MH, Wu QQ, et al. The tear proteomics analysis of conjunctivochalasis［J］. Zhonghua Yan Ke Za Zhi, 2009, 45（2）: 135-140.
67. Mimura T, Usui T, Yamamoto H, et al. Conjunctivochalasis and contact lenses［J］. Am J Ophthalmol, 2009, 148（1）: 20-25.
68. Erdogan-Poyraz C, Mocan MC, Bozkurt B, et al. Elevated tear interleukin-6 and interleukin-8 levels in patients with conjunctivochalasis［J］. Cornea, 2009, 28（2）: 189-193.
69. Mimura T, Yamagami S, Usui T, et al. Changes of conjunctivochalasis with age in a hospital-based study［J］. Am J Ophthalmol, 2009, 147（1）: 171-177.
70. Brodbaker E, Bahar I, Slomovic AR. Novel use of fibrin glue in the treatment of conjunctivochalasis［J］. Cornea, 2008, 27（8）: 950-952.
71. Acera A, Rocha G, Vecino E, et al. Inflammatory markers in the tears of patients with ocular surface disease［J］. Ophthalmic Res, 2008, 40（6）: 315-321.
72. Maskin SL. Effect of ocular surface reconstruction by using amniotic membrane transplant for symptomatic conjunctivochalasis on fluorescein clearance test results［J］. Cornea, 2008, 27（6）: 644-649.
73. Yokoi N, Inatomi T, Kinoshita S. Surgery of the conjunctiva［J］. Dev Ophthalmol, 2008, 41: 138-158.
74. Wang Y, Dogru M, Matsumoto Y, et al. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings［J］. Am J Ophthalmol, 2007, 144（6）: 930-937.
75. Fernández-Hortelano A, Moreno-Montañés J, Heras-Mulero H, et al. Amniotic membrane transplantation with fibrin glue as treatment of refractory conjunctivochalasis［J］. Arch Soc Esp Oftalmol, 2007, 82（9）: 571-574.
76. Kheirkhah A, Casas V, Blanco G, et al. Amniotic membrane transplantation with fibrin glue for conjunctivochalasis［J］. Am J Ophthalmol, 2007, 144（2）: 311-313.
77. Kheirkhah A, Casas V, Esquenazi S, et al. New surgical approach for superior conjunctivochalasis［J］. Cornea, 2007, 26（6）: 685-691.
78. Haefliger IO, Vysniauskiene I, Figueiredo AR, et al. Superficial conjunctiva cauterization to reduce moderate conjunctivochalasis［J］. Klin Monbl Augenheilkd, 2007, 224（4）: 237-239.
79. Erdogan-Poyraz C, Mocan MC, Irkec M, et al. Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion［J］. Cornea, 2007, 26（3）: 290-293.
80. Gao YY, Di Pascuale MA, Elizondo A, Tseng SC. Clinical treatment of ocular demodecosis by lid scrub with tea tree oil［J］. Cornea, 2007, 26（2）: 136-143.
81. Erb MH, Uzcategui N, Dresner SC. Efficacy and complications of the transconjunctival entropion repair for lower eyelid involutional entropion［J］. Ophthalmology, 2006, 113（12）: 2351-2356.
82. Murube J. Characteristics and etiology of conjunctivochalasis: historical perspective［J］. Ocul Surf, 2005, 3（1）: 7-14.
83. Uchino M, Dogru M, Yagi Y, et al. The features of dry eye disease in a Japanese elderly population［J］. Optom Vis Sci, 2006, 83（11）: 797-802.
84. de Almeida SF, de Sousa LB, Vieira LA, et al. Clinic-cytologic study of conjunctivochalasis and its relation to thyroid autoimmune diseases: prospective cohort study［J］. Cornea, 2006, 25（7）: 789-793.
85. Yoon SW, Yoon YS, Lee SH. Clinical results of endoscopic dacryocystorhinostomy using a microdebrider［J］. Korean J Ophthalmol, 2006, 20（1）: 1-6.
86. Yokoi N, Komuro A, Nishii M, et al. Clinical impact of conjunctivochalasis on the ocular surface［J］. Cornea, 2005, 24（8 Suppl）: S24-S31.
87. Chan DG, Francis IC, Filipic M, et al. Clinicopathologic study of conjunctivochalasis［J］. Cornea, 2005, 24（5）: 634.
88. Francis IC, Chan DG, Kim P, et al. Case-controlled clinical and histopathological study of conjunctivochalasis［J］. Br J Ophthalmol, 2005, 89（3）: 302-305.
89. Watanabe A, Yokoi N, Kinoshita S, et al. Clinicopathologic study of conjunctivochalasis［J］. Cornea, 2004, 23（3）: 294-298.
90. Zhang XR, Cai RX, Wang BH, et al. The analysis of histopathology of conjunctivochalasis［J］. Zhonghua Yan Ke Za Zhi, 2004, 40（1）: 37-39.
91. Di Pascuale MA, Espana EM, Kawakita T, et al. Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency［J］. Br J Ophthalmol, 2004, 88（3）: 388-392.
92. Hirotani Y, Yokoi N, Komuro A, et al. Age-related changes in the mucocutaneous junction and the conjunctivochalasis in the lower lid margins［J］. Nihon Ganka Gakkai Zasshi, 2003, 107（7）: 363-368.
93. Zhang M, Chen JQ, Liu ZG, et al. Clinical characteristics of patients with dry eye syndrome［J］. Zhonghua Yan Ke Za Zhi, 2003, 39（1）: 5-9.
94. Yokoi N, Komuro A, Maruyama K, et al. New surgical treatment for superior limbic keratoconjunctivitis and its association with conjunctivochalasis［J］. Am J Ophthalmol, 2003, 135（3）: 303-308.
95. Yokoi N, Komuro A, Sugita J, et al. Surgical reconstruction of the tear meniscus at the lower lid margin for treatment of conjunctivochalasis［J］. Adv Exp Med Biol, 2002, 506（Pt B）: 1263-1268.
96. Francis IC, Wan MK. The punctal apposition syndrome: a new surgical approach［J］. Br J Ophthalmol, 2002, 86（11）: 1256-1258.
97. Kruse FE, Meller D. Amniotic membrane transplantation for reconstruction of the ocular surface［J］. Ophthalmologe, 2001, 98（9）: 801-810.
98. Georgiadis NS, Terzidou CD. Epiphora caused by conjunctivochalasis: treatment with transplantation of preserved human amniotic membrane［J］. Cornea, 2001, 20（6）: 619-621.
99. Meller D, Maskin SL, Pires RT, et al. Amniotic membrane transplantation for symptomatic conjunctivochalasis refractory to medical treatments［J］. Cornea, 2000, 19（6）: 796-803.
100. Meller D, Li DQ, Tseng SC. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha［J］. Invest Ophthalmol Vis Sci, 2000, 41（10）: 2922-2929.
101. Otaka I, Kyu N. A new surgical technique for management of conjunctivochalasis［J］. Am J Ophthalmol, 2000, 129（3）: 385-387.
102. Li DQ, Meller D, Liu Y, et al. Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts［J］. Invest Ophthalmol Vis Sci, 2000, 41（2）: 404-410.
103. Eifrig DE. Grading conjunctivochalasis［J］. Surv Ophthalmol, 1999, 44（1）: 93-94.
104. Meller D, Tseng SC. Reconstruction of the conjunctival and corneal surface. Transplantation of amnionic membrane［J］. Ophthalmologe, 1998, 95（12）: 805-813.
105. Meller D, Tseng SC. Conjunctivochalasis: literature review and possible pathophysiology［J］. Surv Ophthalmol, 1998, 43（3）: 225-232.
106. Jordan DR, Pelletier CR. Conjunctivochalasis［J］. Can J Ophthalmol, 1996, 31（4）: 192-193.
107. Serrano F, Mora LM. Conjunctivochalasis: a surgical technique［J］. Ophthalmic Surg, 1989, 20（12）: 883-884.
108. Liu D. Conjunctivochalasis. A cause of tearing and its management［J］. Ophthal Plast Reconstr Surg, 1986, 2（1）: 25-28.